1301 - Selective NIK Inhibition Overcomes Microenvironment-Mediated Resistance and Synergizes with Venetoclax in CLL

Primary Author / Presenter(s)

IA

Iona Ashworth, MD

Brighton & Sussex Medical School, England, United Kingdom

EK

Emma M. Kennedy, PhD

Post-Doctoral Research Scientist
Brighton and Sussex Medical School
Brighton, England, United Kingdom
LS

Lauren Stott, MSc

Brighton and Sussex Medical School
Brighton, England, United Kingdom
JJ

John Jones, MD, PhD

East Sussex Healthcare NHS Trust
Eastbourne, England, United Kingdom
RJ

Rosalynd Johnston, MD

University Hospitals Sussex NHS Foundation Trust
Brighton, England, United Kingdom
EL

Eleni Ladikou, MD, PhD

East Sussex Healthcare NHS Trust
Eastbourne, England, United Kingdom
SM

Simon Mackay, PhD

University of Strathclyde
Strathclyde, Scotland, United Kingdom
Silvia Deaglio, MD, PhD

Professor of Medical Genetics
University of Turin
Turin, Italy
TV

Tiziana Vaisitti, PhD

University of Turin
Torino, Piemonte, Italy
FS

Fabio Simoes, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
SM

Simon Mitchell, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
Andrea Pepper, PhD

Brighton and Sussex Medical School
University of Sussex
Brighton, England, United Kingdom
CP

Chris Pepper, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom